A Case of First-line Atezolizumab Plus Bevacizumab Use in Recurrence of Combined Hepatocellular Cholangiocarcinoma After Surgical Resection
J Clin Exp Hepatol
.
2024 Sep-Oct;14(5):101430.
doi: 10.1016/j.jceh.2024.101430.
Epub 2024 Apr 16.
Authors
Gordon T Moffat
1
2
,
Kai Duan
3
4
,
Jennifer J Knox
1
2
Affiliations
1
Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
2
Department of Oncology, University of Toronto, Toronto, Ontario, Canada.
3
Department of Anatomical Pathology, Toronto General Hospital, Toronto, Ontario, Canada.
4
Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
PMID:
38766623
PMCID:
PMC11097066
(available on
2025-09-01
)
DOI:
10.1016/j.jceh.2024.101430
No abstract available